MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism
MDMX is overexpressed in the vast majority of patients with acute myeloid leukemia (AML). We report that MDMX overexpression increases preleukemic stem cell (pre-LSC) number and competitive advantage. Utilizing five newly generated murine models, we found that MDMX overexpression triggers progressio...
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Cell Press
2021
|